Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models.

导出 LinkOut

翻译打印收藏纠错

作者： Mingfeng,Xia ^[1] ; Shunxing,Rong ^[2] ; Xiaopeng,Zhu ^[3] ; Hongmei,Yan ^[3] ; Xinxia,Chang ^[1] ; Xiaoyang,Sun ^[2] ; Hailuan,Zeng ^[1] ; Xiaoming,Li ^[2] ; Linshan,Zhang ^[1] ; Lingyan,Chen ^[2] ; Li,Wu ^[1] ; Hui,Ma ^[2] ; Yu,Hu ^[1] ; Wanyuan,He ^[2] ; Jian,Gao ^[1] ; Baishen,Pan ^[1] ; Xiqi,Hu ^[2] ; Huandong,Lin ^[1] ; Hua,Bian ^[4] ; Xin,Gao ^[1]

作者单位： Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China. ^[1] Fudan Institute for Metabolic Diseases, Shanghai, China. ^[2] Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[3] Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, China. ^[4] Department of Ultrasonography, Zhongshan Hospital, Fudan University, Shanghai, China. ^[5] Center of Clinical Epidemiology and EBM of Fudan University, Shanghai, China. ^[6] Department of Nutrition, Zhongshan Hospital of Fudan University, Shanghai, China. ^[7] Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. ^[8] Department of Pathology, Medical College, Fudan University, Shanghai, China. ^[9]

关键词 BONE-LIVER INTERACTION HEPATIC DE NOVO LIPOGENESIS NAFLD OSTEOCALCIN SREBP-1C